AXCELLA HEALTH INC's ticker is AXLA and the CUSIP is 05454B105. A total of 40 filers reported holding AXCELLA HEALTH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,481 | – | 25,108 | +502060.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 5 | -99.3% | 0.00% | – |
| Q2 2022 | $1,000 | -75.0% | 700 | -57.5% | 0.00% | – |
| Q1 2022 | $4,000 | +33.3% | 1,647 | -4.0% | 0.00% | – |
| Q4 2021 | $3,000 | -40.0% | 1,716 | -1.7% | 0.00% | – |
| Q3 2021 | $5,000 | -44.4% | 1,746 | -27.2% | 0.00% | – |
| Q2 2021 | $9,000 | +800.0% | 2,399 | +1428.0% | 0.00% | – |
| Q1 2021 | $1,000 | -98.4% | 157 | -98.7% | 0.00% | – |
| Q4 2020 | $61,000 | -44.5% | 11,675 | -51.0% | 0.00% | – |
| Q3 2020 | $110,000 | +205.6% | 23,815 | +260.0% | 0.00% | – |
| Q2 2020 | $36,000 | +1700.0% | 6,615 | +804.9% | 0.00% | – |
| Q1 2020 | $2,000 | -95.2% | 731 | -93.0% | 0.00% | – |
| Q4 2019 | $42,000 | +1300.0% | 10,446 | +1936.3% | 0.00% | – |
| Q3 2019 | $3,000 | -94.6% | 513 | -91.5% | 0.00% | – |
| Q2 2019 | $56,000 | – | 6,051 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 2,807,981 | $14,573,000 | 5.70% |
| Flagship Pioneering Inc. | 12,548,414 | $65,126,000 | 1.19% |
| Artal Group S.A. | 712,500 | $3,698,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 30,713 | $159,000 | 0.03% |
| ZACKS INVESTMENT MANAGEMENT | 132,915 | $690,000 | 0.01% |
| Virtu Financial LLC | 15,682 | $81,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 187,122 | $971,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 62,467 | $324,000 | 0.01% |
| FMR LLC | 5,631,132 | $29,226,000 | 0.00% |
| MARSHALL WACE, LLP | 60,307 | $313,000 | 0.00% |